Navigation Links
China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results
Date:6/1/2011

terest expense and amortization in connection with convertible notes were not added back in computing GAAP diluted earnings per ADS because they were anti-dilutive. Non-GAAP earnings per ADS represents non-GAAP net income divided by the weighted average number of ADSs used in computing basic and diluted earnings per ADS in accordance with GAAP.(9) As a result of the adoption of new authoritative guidance governing the accounting for own-share lending arrangements in contemplation of convertible debt issuance or other financing, effective on April 1, 2010,  the Company adjusted relevant numbers in the unaudited condensed consolidated statements of income for the year ended March 31, 2010 retrospectively in accordance with GAAP.China Medical Technologies, Inc.Unaudited Condensed Consolidated Statements of Cash FlowsFor the Three Months EndedMarch 31, 2010March 31, 2011RMBRMBUS$(in thousands)Net cash provided by operating activities

59,75837,3395,702Net cash provided by (used in) investing activities

(609)18,7892,869Net cash used in financing activities

(73,596)(48,921)(7,471)Effect of foreign currency exchange rate change on cashand cash equivalents

13(2,773)(423)Net increase (decrease) in cash and cash equivalents

(14,434)4,434677Cash and cash equivalents:At beginning of period

829,8871,119,384170,943At end of period

815,4531,123,818171,620For the Year EndedMarch 31, 2010March 31, 2011RMBRMB
'/>"/>

SOURCE China Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... MARSEILLE , Frankreich, July ... , Weltweite Exklusivlizenz der Universität ... Entwicklung von Tests auf SF3B1-Mutationen, einschließlich von ... Neuer Test weist Mutationen des SF3B1-Gens nach, ... einen günstigen Krankheitsverlauf vermuten lassen  ...
(Date:7/24/2014)... Inc. (NasdaqGS: ABAX ), a medical products ... results for the first fiscal quarter ended June 30, ... of $47.5 million, up 10% over last year,s comparable ... over last year,s comparable quarter. Revenues highlights: ... 20% over last year,s comparable quarter. , Veterinary ...
(Date:7/24/2014)... THOUSAND OAKS, Calif. , July 24, 2014 ... will report its second quarter financial results on Tuesday, July ... The announcement will be followed by a conference call with ... call from Amgen will be Robert A. Bradway , ... senior management team. Live audio of the conference ...
Breaking Medicine Technology:QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11Amgen Announces Webcast of 2014 Second Quarter Financial Results 2
... Calif., March 19, 2012 diaDexus, Inc. (OTC Bulletin ... proprietary cardiovascular diagnostic products, today highlighted data from two ... Test for Lp-PLA(2)  Activity.  The PLAC® Test for Lp-PLA(2) ... States and is an investigational assay in the United ...
... 2012  Nouveau Life Pharmaceuticals, soon to be changed from ... announced today that Advent Financial, a leading financial analyst ... 5-year revenue for the Company at $42MM.  Advent has ... experience at large investment banks including Bank of America, ...
Cached Medicine Technology:diaDexus, Inc. Highlights Findings from Two Outcomes Studies for its PLAC Lp-PLA(2) Activity Assay 2diaDexus, Inc. Highlights Findings from Two Outcomes Studies for its PLAC Lp-PLA(2) Activity Assay 3diaDexus, Inc. Highlights Findings from Two Outcomes Studies for its PLAC Lp-PLA(2) Activity Assay 4diaDexus, Inc. Highlights Findings from Two Outcomes Studies for its PLAC Lp-PLA(2) Activity Assay 5diaDexus, Inc. Highlights Findings from Two Outcomes Studies for its PLAC Lp-PLA(2) Activity Assay 6Leading Financial Analyst Group Estimates 5-Year Revenue for HRID at $42MM 2
(Date:7/25/2014)... (PRWEB) July 26, 2014 According ... Monitoring Market by Product (vibration monitoring, thermography, ultrasound ... signature analysis), Component, Application and Geography - Global ... the machine health monitoring market is expected to ... 2014 to 2020. , Browse 117 market data ...
(Date:7/25/2014)... New York, NY (PRWEB) July 25, 2014 ... cut ticket prices across the board for the Guinness ... Liverpool FC and Olympiacos FC at Soldier Field ... is also offering their customer appreciation promo/coupon/offer code SOCCER-2014 ... be an amazing year for diehard soccer fans in ...
(Date:7/25/2014)... As reported by Wood TV 8 in the ... has seen a nearly 500-person increase in heroin related overdose ... 271 between 1999 and 2002, the toll increased to 728 ... other states, drug users in Michigan have turned to heroin ... compared the price of both substances, noting that an 80-milligram ...
(Date:7/25/2014)... -- The human brain can preserve oxygen to protect ... finds. Although dehydration significantly reduces blood flow ... the brain compensates by increasing the amount of oxygen ... helped us understand a lot more about how the ... study first author Steven Trangmar, a researcher at Brunel ...
(Date:7/25/2014)... Ticket Down is a reliable source for cheap ... California Memorial Stadium. With the post-World Cup emotions still rolling ... the 2014 Guinness International Champions Cup have brought eight of ... representing La Liga, English Premier League, Serie A, and Superleague ... players from around the world to 12 American cities and ...
Breaking Medicine News(10 mins):Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Liverpool FC vs. Olympiacos FC Tickets Soldier Field: Ticket Down Slashes Ticket Prices for Guinness International Champions Cup in Chicago on Sunday, July 27th 2Health News:Rise in Heroin Use, Overdose Deaths in Michigan 2Health News:Human Brain Has Coping Mechanism for Dehydration 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 3
... WuXi PharmaTech (Cayman) Inc.,(NYSE: WX ), a ... and medical device industries, with operations,in China and the ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ), ... 2009 Net Revenues Increase 5% Year Over Year to, ...
... Hundreds of Grass-Roots Activists and Scientific Leaders Meet in Nashville for Al ... ... -- The Climate Project (TCP), an international non-profit founded by former Vice ... climate crisis at a grassroots level worldwide, is opening its North American ...
... Quest Diagnostics Incorporated (NYSE: DGX ), the ... today announced that its Board of Directors declared a ... $0.10 per share, payable on July 20, 2009, to ... Diagnostics , Quest Diagnostics is the world,s leading ...
... MDAs policymakers consider ways to cut health costs as ... of physician practices finds that physicians on average are ... administrative tasks required by health plans. According to ... Weill Cornell Medical College and colleagues, physician practices report ...
... Health Systems, ,party philanthropy, and a caring young girl ... King Cardiac Foundation (LKCF), founded by internationally acclaimed ... its goal to Save a Heart a Day ... have received life saving cardiac treatment from the Foundation ...
... Corporation announced today that it has entered into a multi-year, sole-source ... in infant formulas and growing-up milks produced by Lactalis and sold ... ... May 14, 2009 - Martek Biosciences Corporation (NASDAQ: MATK) ...
Cached Medicine News:Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 2Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 3Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 4Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 5Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 6Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 7Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 8Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 9Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 10Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 11Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 12Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 13Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 14Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 15Health News:The Climate Project Brings Together Historic Gathering of World's Experts on Climate Change 2Health News:The Climate Project Brings Together Historic Gathering of World's Experts on Climate Change 3Health News:The Climate Project Brings Together Historic Gathering of World's Experts on Climate Change 4Health News:Physician practice interactions with health plans cost $31 billion a year 2Health News:Physician practice interactions with health plans cost $31 billion a year 3Health News:The Larry King Cardiac Foundation Achieves Record Life-Saving Pace With Help From New Friends and Partners 2Health News:Martek Signs Sole-Source ARA Supply Agreement with Lactalis Nutrition Sante 2Health News:Martek Signs Sole-Source ARA Supply Agreement with Lactalis Nutrition Sante 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 8 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 19.0 mm and length 21 mm....
The Vitek 2 is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat bacte...
IDS Rapid STR, a microbial identification system....
Medicine Products: